1996
DOI: 10.1016/s0041-008x(96)80019-6
|View full text |Cite
|
Sign up to set email alerts
|

Protective effect of an inhibitor of nitric oxide synthase on sulphur mustard toxicity in vitro

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
16
0

Year Published

1998
1998
2010
2010

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 34 publications
(18 citation statements)
references
References 30 publications
2
16
0
Order By: Relevance
“…HD toxicity may represent a third pathway that does not involve activation of NOS. However, in spite of the fact that NOS is not activated, it has been shown that NOS inhibitor (Sawyer et al, 1996), thiocitrulline (Sawyer et al, 1998), arginine analogs (Sawyer et al, 2000) or in combination with other drugs (Rappeneau et al, 2000), protect cells against HD toxicity in an unknown mechanism. In our experiments the NOS inhibitor L-NMMA did not protect the RAW264.7 cell line from any HD cytotoxicity.…”
Section: Discussionmentioning
confidence: 99%
“…HD toxicity may represent a third pathway that does not involve activation of NOS. However, in spite of the fact that NOS is not activated, it has been shown that NOS inhibitor (Sawyer et al, 1996), thiocitrulline (Sawyer et al, 1998), arginine analogs (Sawyer et al, 2000) or in combination with other drugs (Rappeneau et al, 2000), protect cells against HD toxicity in an unknown mechanism. In our experiments the NOS inhibitor L-NMMA did not protect the RAW264.7 cell line from any HD cytotoxicity.…”
Section: Discussionmentioning
confidence: 99%
“…1). Pretreatment with DRDE-30 did not protect completely the SM induced liver lesions, and pretreat- chemical decontamination Smith et al, 1995); antihistaminics (Yourick et al, 1995); bioflavonoids (Vijayaraghavan et al, 1991;Om Kumar et al, 2001); anti-inflammatory agents (Yourick et al, 1995;Zhang et al, 1995;Casillas et al, 2000;Amir et al, 2000); Xanthine oxidase inhibitors (Papirmeister et al, 1991); NAD + level stabilisers (Mol, et al, 1989;Yourick et al, 1991;Meier and Johnson, 1992;Yourick et al, 1995); intracellular scavengers of SM (Zhang et al, 1995); PARP inhibitors (Meier et al, 2000); nitric oxide synthase inhibitors (Sawyer, 1998a;1998b) and arginine analogues (Sawyer et al, 1996). Some PARP inhibitors and povidone iodine ointment (Wormser et al, 2000) were found to be effective as post-treatment also.…”
Section: Effect Of Analogues On Histological Lesions Induced By Sm Inmentioning
confidence: 99%
“…Although many compounds have shown good prophylactic as well as therapeutic protection in vitro (Sawyer, 1998a;1998b;Sawyer et al, 1996;Sawyer and Risk, 2000), their in vivo efficacy is questionable. To date there is no definitive therapy to counteract the toxic effects of SM on the body.…”
Section: Introductionmentioning
confidence: 99%
“…(a) Prevention of SM from entering the system (personal decontamination at the site of contact), Several antidotes have been reported for reducing the systemic toxicity of SM in experimental animals [9][10][11][12][13][14][15] . Most of the antidotes are in various stages of development and so far none recommended.…”
Section: Introductionmentioning
confidence: 99%